Table 3 Comparison of AMR phenotype vs genotype.
Antimicrobial | Resistant phenotype N (%) | Major error N (%) | Very major error N (%) | Determinants (% of resistance explained) |
---|---|---|---|---|
Ceftriaxone | 47 (16.3%) | 2 (0.8%) | 5 (11%) | blaCTX-M-15 (71%), blaCTX-M-14 (13%) |
Meropenem | 4 (1.4%) | 1 (0.3%) | 0 (0%) | blaIMP-4 (50%), blaOXA-48 (50%) |
Ciprofloxacin | 42 (15.0%) | 15 (6.0%) | 6 (14%) | qnrB1 (61%), qnrS1 (7%), GyrA-83 (32%), GyrA-87 (16%), ParC-80 (23%) * |
Gentamicin | 11 (3.7%) | 0 (0%) | 1 (9%) | aac(6’)-Ib-cr (79%), rmtB (15%), aac3-IIa (15%), aac3-IId (12%), aadA2 (9%), ant(2”)-Ia (9%), aac(6’)-Ib4 (6%) |
Tobramycin | 32 (10.8%) | 1 (0.4%) | 1 (3%) | |
Amikacin | 7 (2.4%) | \({\!}^{\S}\)0 (0%) | \({\!}^{\S}\)2 (29%) | |
Trimethoprim | 70 (23.8%) | 2 (0.9%) | 14 (20%) | dfrA14 (51%), dfrA12 (6%); +sul2 (89%), +sul1 (29%) |
+Sulfamethoxazole | 54 (18.4%) | 4 (1.7%) | 4 (7%) |